Evolution of the Average Target: Valneva SE

Data source: Valneva SE(VLA)
Evolution of the Average Target - Valneva SE

Evolution of the Target Price: Valneva SE

Data source: Valneva SE(VLA)
Evolution of the Target Price - Valneva SE

Changes in Analyst Recommendations: Valneva SE

Data source: Valneva SE(VLA)
85dfc3d382105f22d.0JofagYW2DyvUBVikMNaDOklV5wqB2x3YANRDcQVxyc.vPRMNVBeh1meOn9V6oIdbp4QHs1hNhkOUDszNYhzoVDp8lMIXHKTDOc9QA~9c777d92f4ce3aeec9dca6a212f5ebf4
08-11 TD Cowen Initiates Valneva at Buy Rating, With $12 Price Target MT
05-13 French Analyst Ratings: Aramis and Valneva penalized following profit warnings Zonebourse
04-30 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
04-22 Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50 MT
04-22 French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight Zonebourse
03-18 Valneva heads for fourth consecutive gain following annual results Zonebourse
01-20 Stifel Reiterates Buy Rating and Price Target on Valneva Zonebourse
01-06 Valneva, Biggest Gainer on SBF 120 and SRD at Close of Tuesday, January 6, 2026 Zonebourse
01-06 Valneva Surges on Positive Broker Comments Zonebourse
01-06 CAC 40 Lags Behind; Valneva in Demand Zonebourse
01-06 Valneva Posts Strongest Midday Gain on SBF 120, Tuesday, January 6, 2026 Zonebourse
01-06 Stock of the Day in Paris – Valneva Bolstered by Stifel Zonebourse
01-06 Stifel Raises Price Target for Valneva Zonebourse
01-06 Analysts' calls of the day: Bernstein favors Thales over BAE Systems and Dassault Aviation Zonebourse
11-20 Stifel Reiterates Buy Recommendation on Valneva Zonebourse
11-04 Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601 CI
25-09-03 Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises RE
25-08-26 Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License Zonebourse
25-08-26 Valneva: Stifel adjusts target price Zonebourse
25-08-12 Valneva: Oddo BHF confirms 'outperform' rating Zonebourse
25-07-14 Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine RE
24-08-13 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
24-06-24 Valneva rises after Canadian approval for its chikungunya vaccine RE
24-02-05 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
24-01-02 Valneva: Oddo BHF remains positive Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+41.72%
+26.36%
+10.61%
+10.61%
+16.9%
+37.16%
+42.61%
-17.48%
+30.19%
Average +22.07%
Weighted average by Cap. +22.71%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.560EUR
Average target price
6.200EUR
Spread / Average Target
+142.19%
High Price Target
12.00EUR
Spread / Highest target
+368.75%
Low Price Target
2.200EUR
Spread / Lowest Target
-14.06%

Analyst Consensus Detail

Analyst consensus - Valneva SE

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Valneva SE
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Valneva SE